Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Valproic acid: a migraine prophylaxis alternative

C E Shelton1, J F Connelly

  • 1Whitesburg Appalachian Regional Healthcare, KY 41858, USA.

The Annals of Pharmacotherapy
|July 1, 1996
PubMed
Summary

Valproate is effective for migraine prevention, confirmed by a large clinical trial. This offers a new alternative to traditional migraine treatments, though further research is recommended.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Hyperammonaemia due to ornithine transcarbamylase deficiency.

Archives of disease in childhood·2010
Same author

Suxamethonium-induced hyperkalaemia 6 weeks after chemoradiotherapy in a patient with rectal carcinoma.

British journal of anaesthesia·2007
Same author

Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 1: The screening programme, demography, baseline perinatal data and diagnostic classification.

Journal of pediatric endocrinology & metabolism : JPEM·2002
Same author

Newborn screening for congenital hypothyroidism, Victoria, Australia, 1977-1997. Part 2: Treatment, progress and outcome.

Journal of pediatric endocrinology & metabolism : JPEM·2002
Same author

Publication rates of abstracts from two pharmacy meetings.

The Annals of pharmacotherapy·2000
Same author

Distribution plan for immune globulin intravenous during a shortage.

American journal of health-system pharmacy : AJHP : official journal of the American Society of Health-System Pharmacists·1999

Area of Science:

  • Neurology
  • Pharmacology

Background:

  • Previous studies suggested valproate's potential for migraine prophylaxis but used small sample sizes.
  • Migraine prevention remains a significant clinical challenge, necessitating novel therapeutic options.

Purpose of the Study:

  • To evaluate the effectiveness of valproate in preventing migraine headaches.
  • To assess valproate as a potential alternative to existing migraine prophylactic therapies.

Main Methods:

  • A recent, large-scale clinical trial was conducted to assess valproate's efficacy.
  • Data from this trial were analyzed to confirm the preventive effects of valproate.

Main Results:

  • The large clinical trial confirmed the effectiveness of valproate in migraine prevention.
  • Valproate demonstrates significant potential as a prophylactic agent for migraine sufferers.

Conclusions:

  • Valproic acid represents a viable alternative for migraine prophylaxis.
  • Further large-scale studies are warranted to establish valproate's definitive role in migraine management.
  • The FDA approval of divalproex sodium supports its use in migraine prevention, with standard dosing recommendations.

Related Experiment Videos